News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Senator Lindsey Graham died at 71 after a sudden illness, creating an unexpected U.S. Senate vacancy and near-term legislative uncertainty.
  • Former Qatari Emir Sheikh Hamad bin Khalifa Al-Thani died at 74, triggering a leadership transition in Qatar.
  • Bernstein warns AI tightens market information but can synchronize trading signals and amplify dislocations in stressed periods.
  • Brokers issued divergent AI-era calls, including a Street-high $800 SpaceX target and mixed ratings across cloud, chips and commerce.
  • Bitcoin held above $63,000 amid renewed Iran-related tension and an intensifying U.S. digital-assets regulatory debate.
  • Tactical trade ideas surfaced: Lumen, AppFolio and QIAGEN pitched as AI/automation longs, while BYD was flagged as a mid-term short.

Latest Articles

Evenly Divided Andean District Reflects Peru’s Deep Political Fault Lines

Evenly Divided Andean District Reflects Peru’s Deep Political Fault Lines

In the mountain district of Lahuaytambo, 181 votes for Keiko Fujimori and 181 for Roberto Sanchez during the June 7 presidential runoff present a stark local reflection of a nationally tight and polarized race. The tie illustrates persistent rural-urban divides, widespread distrust of political elites and competing local priorities that center on i…

Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine

Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine

Invivyd, Inc. announced completion of enrollment for their Phase 3 LIBERTY clinical trial evaluating the safety, tolerability, and immune response of their investigational COVID-19 monoclonal antibody VYD2311 compared to mRNA COVID-19 vaccines, including co-administration effects. The trial is part of Invivyd's broader REVOLUTION clinical program t…

SpaceX to Buy Cursor Creator Anysphere in $60 Billion All-Stock Deal

SpaceX to Buy Cursor Creator Anysphere in $60 Billion All-Stock Deal

SpaceX announced it will acquire Anysphere, the developer of the AI coding tool Cursor, in an all-stock transaction valuing the software company at $60 billion. The deal, signed June 16, 2026, calls for a merger between SpaceX subsidiary X67 Inc. and Cursor and is expected to close in the third quarter of 2026. Cursor shareholders will receive Spac…

SD Government announces Federal Aviation Administration STC approval for Gogo Galileo HDX installation on the Pilatus PC-12

SD Government announces Federal Aviation Administration STC approval for Gogo Galileo HDX installation on the Pilatus PC-12

Gogo Inc.'s government-focused subsidiary, SD Government, in partnership with Pilatus and Pro Star Aviation, has received FAA Supplemental Type Certificate approval to install the Gogo Galileo HDX connectivity system on the Pilatus PC-12 turboprop. This enables high-speed, low-latency global satellite connectivity for government, defense, and speci…

Aya Gold & Silver Added to the VanEck Gold Miners ETF (GDX)

Aya Gold & Silver Added to the VanEck Gold Miners ETF (GDX)

Aya Gold & Silver Inc., a Canadian precious metals mining company with operations in Morocco, announced its inclusion in the VanEck Gold Miners ETF (GDX) effective June 19, 2026. This milestone reflects the company's recent growth achievements and is expected to enhance the stock's liquidity and visibility among a global investor base.

HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata

HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata

HCW Biologics announced encouraging preliminary results from its Phase 1 dose-escalation clinical trial evaluating HCW9302, an IL-2 based fusion immunotherapeutic, in patients with alopecia areata. All participants in the second dose cohort (3 mcg/kg) showed clinical improvement in hair loss severity scores with good tolerability and no severe side…

AMD and Rackspace Technology Sign Definitive Agreement for Phased Deployment of  30 MW of AMD AI Compute

AMD and Rackspace Technology Sign Definitive Agreement for Phased Deployment of 30 MW of AMD AI Compute

AMD and Rackspace Technology have signed a definitive agreement to deploy 30 MW of AMD-based AI compute infrastructure across Rackspace's global data centers from late 2026 through 2028. This partnership aims to deliver a governed AI stack focused on regulated industries, combining AMD's AI-optimized CPUs and GPUs with Rackspace's enterprise AI clo…

Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial

Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial

Pasithea Therapeutics announced amendments to its Phase 1/1b clinical trial protocol for PAS-004 in neurofibromatosis type 1 (NF1) patients. The changes include additional higher dose levels (24mg and 32mg), the ability to backfill prior cohorts, extended treatment periods up to 18 months, and enhanced imaging and tumor measurement methods. These a…

Verizon Breaks Industry Mold to Put Customers First

Verizon Breaks Industry Mold to Put Customers First

Verizon Communications announced a major customer-focused transformation including an industry-first loyalty program rewarding all customers with Verizon Dollars, the elimination of device activation and upgrade fees, a new simple and affordable Simplicity plan offering premium 5G access for all customers, and the Verizon One converged plan combini…

NovaBridge Biosciences Receives FDA Fast Track Designation for Givastomig in First-Line HER2-Negative Metastatic Gastric Cancer

NovaBridge Biosciences Receives FDA Fast Track Designation for Givastomig in First-Line HER2-Negative Metastatic Gastric Cancer

NovaBridge Biosciences announced that the FDA has granted Fast Track Designation to givastomig, a novel bispecific antibody, combined with nivolumab and chemotherapy for treating patients with previously untreated HER2-negative advanced or metastatic gastroesophageal adenocarcinomas. This designation is expected to accelerate the development and re…

Variant 7 at Scale: A Mid-Term Long on Red Cat’s Maritime Push

Variant 7 at Scale: A Mid-Term Long on Red Cat’s Maritime Push

Red Cat’s Variant 7 (V7) naval autonomy platform is now in full-rate production via Blue Ops. The move materially de-risks delivery and scale for the company’s maritime ambitions and could unlock defense contract momentum. This is a mid-term swing trade idea: a disciplined long with a defined entry at $11.97, stop at $9.50 and target at $18.78 over…

EU Parliament Approves Duty Cuts to Implement U.S. Trade Deal

EU Parliament Approves Duty Cuts to Implement U.S. Trade Deal

The European Parliament on Tuesday voted to reduce import duties on U.S. goods, putting into effect the European Union's commitments under a trade framework agreed last year. The measure, intended to head off a new round of tariffs between the two largest trading partners, implements reciprocal concessions negotiated at a July 2025 meeting in Scotl…

SpaceX to Acquire Anysphere for $60 Billion to Strengthen Enterprise AI Push

SpaceX to Acquire Anysphere for $60 Billion to Strengthen Enterprise AI Push

On June 16, SpaceX announced a $60 billion agreement to buy Anysphere, the company behind the Cursor AI coding agent. The acquisition follows SpaceX's recent Nasdaq debut that valued the firm at more than $2 trillion. SpaceX said the merger is expected to close during the third quarter of 2026 and said the deal could bolster its AI capabilities and…

Deutsche Bank Upgrade Drives GEA Shares Higher as Fundamentals Hold Steady

Deutsche Bank Upgrade Drives GEA Shares Higher as Fundamentals Hold Steady

GEA Group AG shares moved up after Deutsche Bank raised its recommendation from "hold" to "buy" and lifted its price target from €64 to €70, citing a valuation gap. The upgrade came alongside encouraging first-quarter results - 5.3% organic sales growth and a record Q1 EBITDA margin - and follows a prior analyst shift from J.P. Morgan to "neutral" …